Patrick Lebecque
- Molecular Medicine top 1%
-
- Cystic Fibrosis Research Advances 53
- Neonatal Respiratory Health Research 21
- Tracheal and airway disorders 11
- Chronic Obstructive Pulmonary Disease (COPD) Research 9
- Respiratory and Cough-Related Research 6
- Inhalation and Respiratory Drug Delivery 6
- Physiology top 5%
- Asthma and respiratory diseases 16
- Endocrinology top 5%
-
- Pneumonia and Respiratory Infections 5
Patrick Lebecque
97 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Molecular Medicine 344
- Pulmonary and Respiratory Medicine 1.9k
- Applied Microbiology and Biotechnology 80
- Physiology 718
- Endocrinology 89
Countries citing papers authored by Patrick Lebecque
This map shows the geographic impact of Patrick Lebecque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Lebecque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Lebecque more than expected).
Fields of papers citing papers by Patrick Lebecque
This network shows the impact of papers produced by Patrick Lebecque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Lebecque. The network helps show where Patrick Lebecque may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Patrick Lebecque, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2014 | 10 | |
| 3 | 2012 | 1 | |
| 4 | Vardenafil corrects F508del-CFTR localization and chloride transport across the intestinal mucosa | 2012 | 1 |
| 5 | 2011 | 7 | |
| 6 | 2010 | 37 | |
| 7 | 2010 | 40 | |
| 8 | 2009 | 41 | |
| 9 | 2008 | 16 | |
| 10 | Macrophage phenotype in Delta F508-CF mice: Effect of azithromycin | 2007 | 1 |
| 11 | 2007 | 53 | |
| 12 | Reference Ranges for Spirometry Across All Agesbreakdown → | 2007 | 536 |
| 13 | 2006 | 5 | |
| 14 | 2006 | 24 | |
| 15 | 2005 | 30 | |
| 16 | 2002 | 42 | |
| 17 | 1999 | 1 | |
| 18 | 1997 | 52 | |
| 19 | 1995 | 4 | |
| 20 | Effet d'une dose unique de formotérol par voie d'aérosol-doseur chez l'enfant asthmatique. Une étude randomisée, contrôllée, en double aveugle. | 1994 | 1 |
About Patrick Lebecque
Patrick Lebecque is a scholar working on Pulmonary and Respiratory Medicine, Microbiology and Critical Care and Intensive Care Medicine, having authored 99 papers that have together received 3.0k indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (53 papers), Neonatal Respiratory Health Research (21 papers), Asthma and respiratory diseases (16 papers), Tracheal and airway disorders (11 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers), Respiratory and Cough-Related Research (6 papers), Inhalation and Respiratory Drug Delivery (6 papers) and Pneumonia and Respiratory Infections (5 papers). The work is most often cited by research in Molecular Medicine (344 citations), Pulmonary and Respiratory Medicine (1.9k citations) and Applied Microbiology and Biotechnology (80 citations). Patrick Lebecque has collaborated with scholars based in Belgium, France and Canada. Frequent co-authors include Teresinha Leal, Allan L. Coates, Mary Corey, Pierre Wallemacq, Janet Stocks, Mark Rosenthal, Huiqi Pan, John Hankinson, Angie Wade and Sanja Stanojevic. Their work appears in journals such as Journal of Cystic Fibrosis, Pediatric Pulmonology, American Journal of Respiratory and Critical Care Medicine, European Respiratory Journal and European Journal of Pediatrics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.